Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer

PURPOSE: The burden and mechanisms of endocrine therapy-related bone loss have been studied in detail. However, there is limited data regarding cytotoxic chemotherapy’s impact on bone health. There are no definitive guidelines for bone mineral density (BMD) monitoring and treatment with bone-modifyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisha, Yadav, Dubashi, Biswajit, Bobby, Zachariah, Sahoo, Jaya Prakash, Kayal, Smita, Ananthakrishnan, Ramesh, Ganesan, Prasanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004442/
https://www.ncbi.nlm.nih.gov/pubmed/36899284
http://dx.doi.org/10.1007/s11657-023-01231-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004442/
https://www.ncbi.nlm.nih.gov/pubmed/36899284
http://dx.doi.org/10.1007/s11657-023-01231-z

Ejemplares similares